-
News Agency News Aggregator Journalist/Editor Broking House Others
#AjantaPharma share buyback record date set for today. Key details in 5 points Read here:
Almost at 52 w lows now in Ajanta pharma. Again my view of negative stand on this working right despite the buy back.
#AjantaPharma #Buyback Record date 24 March, buyback at 17% premium. Check more details here.
#AjantaPharma #Buyback Record date 24 March, buyback offer INR315 crore. Check more details here.
#AjantaPharma share buyback record date set for Friday, March 24: Know key details here market
#AjantaPharma #Buyback Record date 24 March, buyback at 17% premium. Check more details here.
Intraday Stock Alert #AJANTPHARM - 1202.5 Target 1: 1214.5 Target 2: 1221.95 Target 3: 1233.95 SL: 1156.8 Time: 14.03.2023 1:10 pm Alerts are for educational purpose only. Tools: Live Telegram Alerts:
#OnETNOW | Ajanta Pharma expects a flat US business in constant currency terms, but sees a scope for better margins from FY24, @Sharad9Dubey is here with the details #AjantaPharma
Ajanta Pharma announces buyback of equity shares of Rs. 389 crore #AjantaPharma #INE031B01049 #Buyback #TenderOffer
Ajanta Pharma slipped 1.06%. The drug maker announced that its board has approved a share buyback of upto Rs 315 crore at a price of Rs 1,425 per equity share through tender offer route.
Ajanta Pharma announces ₹ 315 crore share buyback. Details here [Automated tweet]
Midcap Spotlight | Ajanta Pharma approves Rs 315 cr buyback. In our special segment Midcap Spotlight, @ekta_batra gets you all the details
#AjantaPharma #Buyback Board approves INR315-cr buyback at 17% premium. Check more details here.
#AjantaPharma board approves share buyback up to ₹315 cr at ₹1,425/sh via tender route
#AjantaPharma's #stock falls as company announces share buyback, worth up to Rs 315 crore KNOW MORE:
#AjantaPharma shares decline. #BQStocks Read all #stockmarket updates:
-
Trend Analysis

Trade Alerts, Trade Ideas and Crypto 🇺🇸
Trading Ideas: Ajanta Pharma Short Term Breakout 📈 FREE trade-of-week via ⟶